Jazz Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (38)

Latest Posts

About This Stock More About This Stock
Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio
Article By: Benzinga
Thursday, May 6, 2021 10:52 AM EDT
The biopharmaceutical company Jazz Pharmaceuticals, has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc.
In this article: JAZZ, GWPH
Alzheimer's Disease: 5 Stocks On Biotech Radars
Video By: Kevin Cook
Thursday, April 22, 2021 7:53 PM EDT
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other neurological and CNS diseases.
In this video: AVXL, JAZZ, BIIB, AXSM, SAVA
For Jazz Pharmaceuticals, Failure Is The New Winning
Article By: Roddy Boyd
Tuesday, April 6, 2021 4:04 AM EDT
In late June, Jazz Pharmaceuticals began to market a drug aimed at treating people whose metastatic small cell lung cancer has not responded to an initial round of chemotherapy.
In this article: JAZZ Also: BMY, MRK
4 Biotech Stocks To Buy For The Q2 2021
Article By: StockNews
Monday, April 5, 2021 6:45 AM EDT
The global biotechnology market is expected to expand at a CAGR of 15.8% between 2021 – 2028.
In this article: JAZZ, AMGN, GILD, QGEN
Jazz Pharmaceuticals Buys GW Pharma For $7.2 Billion
Video By: CNBC
Wednesday, February 3, 2021 9:39 AM EDT
Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share.
In this video: JAZZ, GWPH

Latest Tweets for $JAZZ

No tweets yet!